首页> 外国专利> Composition for diagnosing colorectal cancer and diagnostic marker detection method

Composition for diagnosing colorectal cancer and diagnostic marker detection method

机译:用于诊断结直肠癌和诊断标记检测方法的组合物

摘要

The present invention relates to a colorectal cancer diagnostic composition and method for detecting a diagnostic marker, more specifically to a colorectal cancer diagnostic composition comprising one or more mRNAs selected from the group consisting of lysyl-tRNA synthetase(KRS) and aminoacyl-tRNA synthetase complex-interacting multifunctional protein 1(AIMP1) of a preparation for measuring protein expression levels thereof, and a method for detecting a marker form a sample obtained from a test subject in order to provide information necessary for diagnosing colorectal cancer. The colorectal cancer diagnostic marker comprising KRS and AIMP1, according to the present invention, has raised expression levels of same in the serum of a colorectal cancer patient in comparison to a normal control group. Therefore, whether colorectal cancer is present can be accurately and rapidly determined by measuring the expression levels of one or more markers selected from the group consisting of KRS and AIMP1.
机译:本发明涉及结肠直肠癌诊断组合物及其用于检测诊断标记的方法,更具体地涉及结直肠癌诊断组合物,其包含一种或多种选自赖氨酸-TRNA合成酶(KRS)和氨基酰基-TRNA合成酶复合物的MRNA - 用于测量其蛋白质表达水平的制剂的互动多功能蛋白1(AIMP1),以及用于检测标记物的方法,形成由测试对象获得的样品以提供诊断结直肠癌所需的信息。根据本发明,包含KRS和AIMP1的结肠直肠癌诊断标志物在与正常对照组相比,在结肠直肠癌患者的血清中引起了相同的表达水平。因此,通过测量选自KRS和AIMP1的组中选择的一种或多种标记的表达水平,可以精确且快速地确定是否存在结直肠癌。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号